Meteora Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Meteora Capital’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.33K	Buy	+114,873	New	+$1.38K	﹤0.01%	351
2025 Q4	–	Sell	-114,873	Closed	-$3.02K	–	421
2025 Q3	$3.02K	Sell	114,873 -135,127	-54%	-$3.57K	﹤0.01%	277
2025 Q2	$6.5K	Sell	250,000 -2,229	-0.9%	-$49	﹤0.01%	160
2025 Q1	$2.72K	Sell	252,229 -174,844	-41%	-$4.58K	﹤0.01%	142
2024 Q4	$9.39K	Sell	427,073 -586,919	-58%	-$14K	﹤0.01%	131
2024 Q3	$15.2K	Sell	1,013,992 -183,082	-15%	-$3.66K	﹤0.01%	150
2024 Q2	$27K	Hold	1,197,074	–	–	﹤0.01%	179
2024 Q1	$30.5K	Buy	1,197,074 +1,048,631	+706%	+$43K	0.01%	179
2023 Q4	$4.6K	Hold	148,443	–	–	﹤0.01%	246
2023 Q3	$3.35K	Hold	148,443	–	–	﹤0.01%	291
2023 Q2	$11.1K	Hold	148,443	–	–	﹤0.01%	248
2023 Q1	$21.9K	Sell	148,443 -143,490	-49%	-$18.5K	﹤0.01%	277
2022 Q4	$29.2K	Buy	+291,933	New	+$19.5K	0.01%	212
2022 Q3	–	Sell	-388,443	Closed	-$18K	–	402
2022 Q2	$18K	Buy	+388,443	New	+$29.2K	﹤0.01%	340

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Meteora Capital's COEPW Position: Q1 2026 in Review

Meteora Capital opened a new position in Coeptis Therapeutics Warrants (COEPW) in Q1 2026: 114,873 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #351 among its holdings. This is a return to the name: Meteora Capital previously reported a position in COEPW as recently as Q3 2025.

Meteora Capital first reported a position in COEPW in Q2 2022 and has held it in 14 quarters since. The position peaked at $30.5K in Q1 2024. 10 funds tracked by Wall St. Rank hold COEPW as of Q1 2026.

Meteora Capital held 114,873 shares of Coeptis Therapeutics Warrants worth $1.33K as of Q1 2026.
Coeptis Therapeutics Warrants was a new Meteora Capital position in Q1 2026.
Coeptis Therapeutics Warrants made up ﹤0.01% of Meteora Capital's portfolio in Q1 2026, its #351 holding.
Meteora Capital first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and has held it in 14 quarters since.
Meteora Capital's Coeptis Therapeutics Warrants position peaked at $30.5K in Q1 2024.
10 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.